11 results about "IV Infusion" patented technology

AI ENABLED IV INFUSION MONITORING DEVICE FOR REAL-TIME NURSING CARE OPTIMISATION

A closed, gravity-fed measured volume burette for intravenous (IV) fluid delivery and flush system supporting multiple input combinations for simplicity and standardization. Able to handle both hazardous and non-hazardous drugs, this system may incorporate plastic and elastomeric materials that are resistant to the effects of antineoplastic materials in conjunction with a hazardous air filter module while still integration compatible with electronic peristaltic pumps for finer control of flow rate and when the IV infusion recipient's physical position is not compatible with a gravity-fed flow. The buoyant-activated shuttle valve enables the AutoStart function providing steady flush of the IV line to the patient for optimized vein patency from the Primary IV fluid feed. This Primary line works in conjunction with a Secondary IV fluid feed and a needleless connector Drug Port for multiple feed and flush conditions directed by way of a monoblock design supporting combinations of rotary, toggle, and check valves.

An IV device assembly may include a lumen that forms a fluidic channel within the IV device assembly. The lumen may be fluidly coupled to a vascular access device (VAD) coupler by a funnel coupler, and an IV device assembly coupler at a proximal end of the lumen. The IV device assembly may also include one or more of the following: a foldable cuff formed coaxially around a first portion of the lumen and mechanically coupled to the funnel coupler, a probe formed along a second portion of the lumen within the foldable cuff and in the VAD coupler, a translation handle that translates the probe from a distal end of the VAD coupler, and a fixed loop formed around the lumen to maintain a position of the IV device assembly relative to the translation handle.

A flushing apparatus for use with an IV infusion set and an IV infusion set having an automatic flushing function. The IV set comprises a rigid and / or non-collapsible flushing liquid chamber (2), that is connected to a fluid flow path for IV fluid from a source of IV fluid to a patient via a flushing port at a flushing height (FH) and via a venting port at a venting height (VH). The venting port comprises an outlet opening (19) that connects to the flushing liquid chamber (2) and an inlet opening (17) that connects to an IV fluid flow path. The outlet opening (19) is arranged higher than the inlet opening (17) and higher than the initial level of the flushing liquid in the flushing liquid chamber (2). The flushing height (FH) is lower than the venting height (VH). When the level of IV liquid in the fluid flow path falls below the venting height (VH) the venting port allows air from the fluid flow path to enter the flushing liquid chamber (2) and flushing liquid from the flushing liquid chamber (2) to enter the fluid flow path via the flushing port when, during use of the IV infusion set the IV liquid level falls below the venting height (VH), thereby allowing the flushing liquid chamber (2) to be drained at least partially by gravity into the fluid flow path.

To provide an improved IV drip rate measurement system and associated drip chamber for use in an IV fluid administration system.SOLUTION: The present disclosure relates to a system for measuring drip rate including a drip chamber device including an elongated body having an inner surface defining a chamber, and a drip rate measurement device. The drip chamber may be fluidly coupled to a container containing IV fluid configured to drip droplets of the IV fluid into the chamber, and the drip rate measurement device may include a housing and a load cell transducer. The load cell transducer may be configured to measure the weight of a droplet of IV fluid and convert the weight into an electrical signal. The drip rate measurement device may include a controller electrically coupled to the load cell transducer to process the electrical signal and output at least one parameter associated with the IV fluid.SELECTED DRAWING: Figure 2B

Infusion connection lines are provided for use with infusion sets. The infusion connection line includes a pump infusion tubing with connectors at both ends and an indicator element to show the installation direction within an infusion pump, which is placed between the connectors. The infusion connection line is configured to connect a gravity IV set to any type of infusion pump while improving pump infusion accuracy and minimizing leakage or tubing breakage by directly over-connecting the gravity IV set to the infusion pump. The infusion connection line can be disconnected and disposed of after use without requiring the removal of the rest of the pump IV infusion set and / or components.

An aseptically prepared pharmaceutically acceptable azithromycin premix formulation has a pH value of 5.5 to 7.5, preferably 6.0 to 7.0, more preferably 6.3 to 7.0, even more preferably 6.3 to 6.7, for example about 6.5. Preferred embodiments of the aseptically prepared pharmaceutically acceptable azithromycin premix formulation contain azithromycin, a buffering agent, water and optionally a tonicity adjusting agent and are stable for one month, three months, six months, nine months, twelve months, fifteen months, eighteen months or even twenty-four months, during storage at refrigerated temperatures, such as about 5° C., even without any additional components beyond the azithromycin, the buffering agent, and the optional tonicity adjusting agent in the premix formulation. The pharmaceutically acceptable azithromycin premix formulation may be aseptically filled into a container, preferably a glass or flexible container, to form a sterile pharmaceutical azithromycin premix product which does not undergo terminal sterilization. The azithromycin premix product can be a single use premix which is a sterile, stable and ready-to-use aqueous solution for parenteral administration, for example intravenous (IV) administration such as IV infusion, and requires no dilution prior to parenteral administration.

An aseptically prepared pharmaceutically acceptable azithromycin premix formulation has a pH value of 5.5 to 7.5, preferably 6.0 to 7.0, more preferably 6.3 to 7.0, even more preferably 6.3 to 6.7, for example about 6.5. Preferred embodiments of the aseptically prepared pharmaceutically acceptable azithromycin premix formulation contain azithromycin, a buffering agent, water and optionally a tonicity adjusting agent and are stable for one month, three months, six months, nine months, twelve months, fifteen months, eighteen months or even twenty-four months, during storage at refrigerated temperatures, such as about 5° C., even without any additional components beyond the azithromycin, the buffering agent, and the optional tonicity adjusting agent in the premix formulation. The pharmaceutically acceptable azithromycin premix formulation may be aseptically filled into a container, preferably a glass or flexible container, to form a sterile pharmaceutical azithromycin premix product which does not undergo terminal sterilization. The azithromycin premix product can be a single use premix which is a sterile, stable and ready-to-use aqueous solution for parenteral administration, for example intravenous (IV) administration such as IV infusion, and requires no dilution prior to parenteral administration.

A closed, gravity-fed measured volume burette for intravenous (IV) fluid delivery and flush system supporting multiple input combinations for simplicity and standardization. Able to handle both hazardous and non-hazardous drugs, this system may incorporate plastic and elastomeric materials that are resistant to the effects of antineoplastic materials in conjunction with a hazardous air filter module while still integration compatible with electronic peristaltic pumps for finer control of flow rate and when the IV infusion recipient's physical position is not compatible with a gravity-fed flow. The buoyant-activated shuttle valve enables the AutoStart function providing steady flush of the IV line to the patient for optimized vein patency from the Primary IV fluid feed. This Primary line works in conjunction with a Secondary IV fluid feed and a needleless connector Drug Port for multiple feed and flush conditions directed by way of a monoblock design supporting combinations of rotary, toggle, and check valves.

Degassing or flushing an IVL catheter balloon. The method includes providing inflation fluid to a catheter balloon from a first fluid reservoir having a positive pressure to inflate the catheter balloon. The method further includes removing at least a portion of the inflation fluid from the catheter balloon to a second fluid reservoir, different from the first fluid reservoir having a negative pressure.